318 related articles for article (PubMed ID: 20957397)
1. Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes.
Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gaudichon C; Tomé D
Amino Acids; 2011 Jul; 41(2):457-68. PubMed ID: 20957397
[TBL] [Abstract][Full Text] [Related]
2. mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat.
Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gausserès N; Steiler T; Gaudichon C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1313-23. PubMed ID: 19738034
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
4. Toxin-induced tail phosphorylation of hepatocellular S6 kinase: evidence for a dual involvement of the AMP-activated protein kinase in S6 kinase regulation.
Møller MT; Samari HR; Seglen PO
Toxicol Sci; 2004 Dec; 82(2):628-37. PubMed ID: 15342961
[TBL] [Abstract][Full Text] [Related]
5. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
6. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
7. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
8. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside.
Reiter AK; Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E980-8. PubMed ID: 15613684
[TBL] [Abstract][Full Text] [Related]
9. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
10. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
Beugnet A; Tee AR; Taylor PM; Proud CG
Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
[TBL] [Abstract][Full Text] [Related]
11. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
Kelly KR; Abbott MJ; Turcotte LP
Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
[TBL] [Abstract][Full Text] [Related]
12. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
14. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
15. AICAR, an activator of AMP-activated protein kinase, down-regulates the insulin receptor expression in HepG2 cells.
Nakamaru K; Matsumoto K; Taguchi T; Suefuji M; Murata Y; Igata M; Kawashima J; Kondo T; Motoshima H; Tsuruzoe K; Miyamura N; Toyonaga T; Araki E
Biochem Biophys Res Commun; 2005 Mar; 328(2):449-54. PubMed ID: 15694368
[TBL] [Abstract][Full Text] [Related]
16. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
17. Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12 myotubes.
Sadiq F; Hazlerigg DG; Lomax MA
BMC Mol Biol; 2007 Mar; 8():23. PubMed ID: 17371596
[TBL] [Abstract][Full Text] [Related]
18. Analysis of microRNA expression profile induced by AICAR in mouse hepatocytes.
Liu J; Liu W; Ying H; Zhao W; Zhang H
Gene; 2013 Jan; 512(2):364-72. PubMed ID: 23107762
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
20. The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells.
Lihn AS; Pedersen SB; Lund S; Richelsen B
Mol Cell Endocrinol; 2008 Sep; 292(1-2):36-41. PubMed ID: 18606210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
